Neuburgh Advisers’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$13K Hold
688
﹤0.01% 901
2019
Q2
$13K Buy
+688
New +$13K ﹤0.01% 895